News & Updates

Late anastomotic leakage after rectal cancer surgery common, milder than early leakage

09 Dec 2021

Late anastomotic leakage (AL) is more common than AL in rectal cancer patients who undergo surgery after neoadjuvant chemoradiotherapy (nCRT) and is less likely to involve require intensive intervention, a recent study has found.

Late anastomotic leakage after rectal cancer surgery common, milder than early leakage

09 Dec 2021

Increased serum iron may hint at HCC risk in NAFLD patients

07 Dec 2021 by

Increased serum iron or transferrin saturation levels in individuals with non-alcoholic fatty liver disease (NAFLD) may point to an increased risk of hepatocellular carcinoma (HCC), according to a study presented at The Liver Meeting Digital Experience™.

Increased serum iron may hint at HCC risk in NAFLD patients

07 Dec 2021

Switching to TAF helps improve virologic response in HBV patients in real world

06 Dec 2021 by

Switching to tenofovir alafenamide (TAF) from nucleos(t)ide analogue therapies was associated with improved virologic response and liver function in patients with chronic hepatitis B virus (HBV) infection, even in those with decompensated HBV cirrhosis, according to real-world studies presented at AASLD 2021.

Switching to TAF helps improve virologic response in HBV patients in real world

06 Dec 2021

Birth control pills pose inflammatory bowel disease risk

06 Dec 2021 by

The use of combined oral contraceptive pills (COCPs) appears to confer some risk of inflammatory bowel disease, which increases accordingly with duration of COCP exposure, as shown in a study.

Birth control pills pose inflammatory bowel disease risk

06 Dec 2021

Interim findings boost therapeutic potential of lanifibranor for NASH

06 Dec 2021 by

The pan-PPAR* agonist lanifibranor further advances into the NASH** treatment field, as more data from the phase IIb NATIVE*** study presented at AASLD 2021 unveil further histologic and therapeutic benefits for patients with NASH.

Interim findings boost therapeutic potential of lanifibranor for NASH

06 Dec 2021

Regular PPI use ups inflammatory bowel disease risk

04 Dec 2021

Regular use of proton pump inhibitors (PPI) seems to slightly aggravate the risk of inflammatory bowel disease, a recent study has found.

Regular PPI use ups inflammatory bowel disease risk

04 Dec 2021

Non-overweight NAFLD patients have poor liver transplant outcomes

03 Dec 2021 by

Non-overweight patients with non-alcoholic fatty liver disease (NAFLD) have an elevated risk of all-cause mortality following liver transplant and are also more likely to be removed from the liver transplant waitlist compared with obese/overweight patients, according to a study presented at The Liver Meeting Digital Experience™.

Non-overweight NAFLD patients have poor liver transplant outcomes

03 Dec 2021

Steroid-free remission in Crohn’s disease does not equate to less progression

03 Dec 2021

For Crohn’s disease patients, achieving a complete and sustained clinical remission off steroids does not necessarily translate to a lower likelihood of experiencing progression, according to data from the TAILORIX trial.

Steroid-free remission in Crohn’s disease does not equate to less progression

03 Dec 2021

Too much calories bad for liver

02 Dec 2021

Consuming high amounts of calories contributes to an increase in the risk of nonalcoholic fatty liver disease (NAFLD), while the diet composition in terms of macronutrients does not seem to be related to the presence or severity of the disease, according to the results of a meta-analysis.

Too much calories bad for liver

02 Dec 2021

Statins not only good for the heart, but also the liver

27 Nov 2021 by

Statins can help preserve liver function in patients with chronic liver disease, according to two studies presented at AASLD 2021— showing that not only are statins protective for the heart, but also for the liver.

Statins not only good for the heart, but also the liver

27 Nov 2021

News & Updates

Filter by Specialty:

Specialty:

Late anastomotic leakage after rectal cancer surgery common, milder than early leakage

Late anastomotic leakage after rectal cancer surgery common, milder than early leakage

Increased serum iron may hint at HCC risk in NAFLD patients

Increased serum iron may hint at HCC risk in NAFLD patients

Switching to TAF helps improve virologic response in HBV patients in real world

Switching to TAF helps improve virologic response in HBV patients in real world

Birth control pills pose inflammatory bowel disease risk

Birth control pills pose inflammatory bowel disease risk

Interim findings boost therapeutic potential of lanifibranor for NASH

Interim findings boost therapeutic potential of lanifibranor for NASH

Regular PPI use ups inflammatory bowel disease risk

Regular PPI use ups inflammatory bowel disease risk

Non-overweight NAFLD patients have poor liver transplant outcomes

Non-overweight NAFLD patients have poor liver transplant outcomes

Steroid-free remission in Crohn’s disease does not equate to less progression

Steroid-free remission in Crohn’s disease does not equate to less progression

Too much calories bad for liver

Too much calories bad for liver

Statins not only good for the heart, but also the liver

Statins not only good for the heart, but also the liver